To directly attack the problem, the Australian and New Zealand national governments must establish a strict and pressing regional awareness program. This must be strictly monitored so as to ensure that at every moment every cent of government funds is being utilized in a manner most conducive to educating the largest number of people in the most profound manner.
Laboratories in Brazil have successfully created a copy of the protease inhibiter indinavir (crixivan) that is originally sold by Merck, worldwide, for higher prices. Normally Brazil's laboratories focus on distribution on it's drugs to local afflicted regions, but in this case, Far Mangunihos, the country's premier research institution, will sell it's products globally for extremely reduced prices.
